India to Turkey: Temozolomide Export Trade Route

The India to Turkey Temozolomide corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $585.6K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $9.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.2%, placing it at rank #1 among India's top temozolomide export destinations globally.

On the import side, key buyers of Indian temozolomide in Turkey include DEM PHARMACEUTICALS, DEM PHARMACEUTICALS DEM ILAC DEM PLAZA INONU MAH, AL HASEM OTOMOTIV TICARET LIMITED S and 14 others. DEM PHARMACEUTICALS is the single largest importer with 15 shipments valued at $471.2K USD.

India's temozolomide exports to Turkey are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $9.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as temozolid 100 mg temozolomide 100 mgnos and temozolid 100 mg temozolomide 100 mg, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DEM PHARMACEUTICALS is the largest importer with 15 shipments worth $471.2K USD — representing 80% of all temozolomide imports from India on this route. A total of 17 buyers are active on this corridor.